共有 50 笔近期内部人交易记录记录，涉及 Pliant Therapeutics, Inc. (PLRX), 包括 32 笔买入 和 16 笔卖出. 内部人买入总额为 $14.05M 内部人卖出总额为 $2.58M.
近期活跃的重要内部人包括 Coulie Bernard, Cummings Keith Lamont, Cheung Lily. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — PLRX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-01-22 |
Coulie Bernard |
President and CEO |
限制性股票授予 (RSU) |
1,230,000 |
$1.30 |
$1.6M |
1,230,000 |
| 2026-01-22 |
Cummings Keith Lamont |
Chief Financial Officer |
限制性股票授予 (RSU) |
400,000 |
$1.30 |
$520K |
400,000 |
| 2026-01-22 |
Cheung Lily |
Chief Human Resource Officer |
限制性股票授予 (RSU) |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-22 |
Kuo Minnie |
Chief Operating Officer |
限制性股票授予 (RSU) |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-20 |
Coulie Bernard |
President and CEO |
知情卖出 |
89,375 |
$1.28 |
$114.4K |
505,601 |
| 2026-01-20 |
Cummings Keith Lamont |
Chief Financial Officer |
知情卖出 |
24,002 |
$1.28 |
$30.72K |
297,214 |
| 2026-01-20 |
Cheung Lily |
Chief Human Resource Officer |
知情卖出 |
7,534 |
$1.28 |
$9.64K |
44,847 |
| 2026-01-20 |
Kuo Minnie |
Chief Operating Officer |
知情卖出 |
6,917 |
$1.28 |
$8.85K |
37,806 |
| 2025-12-10 |
Kuo Minnie |
Chief Operating Officer |
未知 |
55,200 |
$11.14 |
$614.93K |
- |
| 2025-06-05 |
Pyott David E I |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Crowell Gayle A |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Huh Hoyoung |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Mccourt Thomas A |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Bruhn Suzanne Louise |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Curnutte John T |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Cline Darren S |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Krognes Steve E. |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Knobil Katharine |
Director |
限制性股票授予 (RSU) |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-01-23 |
Lefebvre Eric |
Chief Medical Officer |
限制性股票授予 (RSU) |
91,300 |
$11.14 |
$1.02M |
91,300 |
| 2025-01-23 |
Hull Hans |
Chief Business Officer |
限制性股票授予 (RSU) |
80,300 |
$11.14 |
$894.54K |
80,300 |
| 2025-01-23 |
Coulie Bernard |
President and CEO |
限制性股票授予 (RSU) |
325,000 |
$11.14 |
$3.62M |
325,000 |
| 2025-01-23 |
Cummings Keith Lamont |
Chief Financial Officer |
限制性股票授予 (RSU) |
113,300 |
$11.14 |
$1.26M |
113,300 |
| 2025-01-23 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
限制性股票授予 (RSU) |
70,000 |
$11.14 |
$779.8K |
70,000 |
| 2025-01-23 |
Cheung Lily |
Chief Human Resource Officer |
限制性股票授予 (RSU) |
25,875 |
- |
- |
50,425 |
| 2025-01-22 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
知情卖出 |
10,230 |
$10.99 |
$112.46K |
70,544 |
| 2025-01-17 |
Lefebvre Eric |
Chief Medical Officer |
知情卖出 |
18,478 |
$11.20 |
$206.97K |
194,574 |
| 2025-01-17 |
Hull Hans |
Chief Business Officer |
知情卖出 |
15,936 |
$11.20 |
$178.5K |
211,558 |
| 2025-01-17 |
Coulie Bernard |
President and CEO |
知情卖出 |
52,419 |
$11.20 |
$587.15K |
430,517 |
| 2025-01-17 |
Cummings Keith Lamont |
Chief Financial Officer |
知情卖出 |
20,148 |
$11.20 |
$225.68K |
262,608 |
| 2025-01-17 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
知情卖出 |
13,270 |
$11.20 |
$148.64K |
80,774 |
| 2025-01-17 |
Cheung Lily |
Chief Human Resource Officer |
知情卖出 |
3,740 |
$11.20 |
$41.89K |
24,550 |
| 2024-07-10 |
Lefebvre Eric |
Chief Medical Officer |
知情卖出 |
12,319 |
$11.56 |
$142.41K |
213,052 |
| 2024-07-10 |
Hull Hans |
Chief Business Officer |
知情卖出 |
9,900 |
$11.56 |
$114.44K |
227,494 |
| 2024-07-10 |
Coulie Bernard |
President and CEO |
知情卖出 |
38,710 |
$11.56 |
$447.49K |
482,936 |
| 2024-07-10 |
Cummings Keith Lamont |
Chief Financial Officer |
知情卖出 |
10,911 |
$11.56 |
$126.13K |
282,115 |
| 2024-07-10 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
知情卖出 |
7,656 |
$11.56 |
$88.5K |
94,044 |
| 2024-07-09 |
Lefebvre Eric |
Chief Medical Officer |
限制性股票授予 (RSU) |
24,063 |
- |
- |
225,371 |
| 2024-07-09 |
Hull Hans |
Chief Business Officer |
限制性股票授予 (RSU) |
19,337 |
- |
- |
237,394 |
| 2024-07-09 |
Coulie Bernard |
President and CEO |
限制性股票授予 (RSU) |
75,625 |
- |
- |
521,646 |
| 2024-07-09 |
Cummings Keith Lamont |
Chief Financial Officer |
限制性股票授予 (RSU) |
21,313 |
- |
- |
293,026 |
| 2024-07-09 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
限制性股票授予 (RSU) |
14,954 |
- |
- |
101,700 |
| 2024-06-13 |
Pyott David E I |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Crowell Gayle A |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Huh Hoyoung |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Mccourt Thomas A |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Bruhn Suzanne Louise |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Curnutte John T |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Cline Darren S |
Director |
限制性股票授予 (RSU) |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Krognes Steve E. |
Director |
未知 |
- |
- |
- |
- |
| 2024-06-13 |
Krognes Steve E. |
Director |
限制性股票授予 (RSU) |
53,528 |
$13.06 |
$699.08K |
53,528 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
